5-hydroxy-6-oxo-1,6-dihydropyrazine-2,3-dicarbonitrile, 98%, 1g

ETHYL 2-CHLORO-4,6-DIMETHYLPYRIMIDINE-5-CARBOXYLATE, 95.0%, 250mg

1-[3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-pyrrolidine-2,5-dione, 95%, 5g

C-((S)-1-Methyl-pyrrolidin-2-yl)-methylamine, 95.0%, 500mg

1-Butyl-2,3-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V), 95.0%, 25g

2-Bromomethylquinoline, 95.0%, 25g

tert-butyl ((2S)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propan-2-yl)carbamate, 97%, 25mg

Tubes à essai selon. à Durham, 0,5 ml, Hauteur, 25 mm, 250 pièce(s)

Glycidéther 100, 2,5 kg

(S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-4-(trimethylsilyl)butanoic acid hydrochloride, 97%, 100mg

3-IODO-2-NITROPHENOL, 95.0%, 1g

CEFOSELIS SULFATE, 98%, 100mg

1-tert-Butoxycarbonyl-4-hydroxypiperidine, 98.0%, 25g